That's crucial, since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (self-driving cars). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're developed to do. This was a breakthrough almost nobody discovered. But it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of financial investment chances in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown stock picks 2021). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe substantially prior to going greater - bleeding edge. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mostly informing readers. However that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. jeff bezos. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so lots of terrific private business on the verge of striking the public markets And I've been dealing with a brand-new way for you to invest even prior to these companies go public.
This opportunity has actually been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Regular Diary readers understand that tech isn't our normal beat (jeff brown genome sequencing stock). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have a number of such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (self-driving cars). In truth, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid growth and producing amazing chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. biotech stocks jeff brown. But despite what lots of readers might believe, this is a pattern that's simply getting begun. Although the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown investment prediction). Losing two months of production and sales actually impacts how lots of 5G devices are offered in the fiscal year. When you think about all of that, selling 250 million systems is impressive. More significantly, the delays triggered by the pandemic developed a lots of bottled-up demand. Which demand is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown stock predictions 2021. Which's not my only 5G prediction When I've discussed 5G in the past, I've described its 3 different stages.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage 3, 5G services start to be used (jeff brown genetic sequencer stock). That's when we start to see applications working on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summer season. This begins something of a virtuous cycle: The majority of people do not actually appreciate the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of extraordinary applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be massive. Stepping far from 5G, the next essential innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept however with our genetic code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were really only three companies operating in this space. But things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering amazing returns. This entire industry is efficiently a greenfield chance.
There's space for lots of business to exist in this space. self-driving cars. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or three more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can properly forecast the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That is essential due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced using this innovation. This was one of those advancements that almost no one saw. However it's going to have extensive implications for curing disease. And, of course, there will be a lot of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it pulled back maybe substantially prior to going greater. I've been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin - biotech stocks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. tech stocks. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we might not separately confirm this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like ability to choose winning technology stocks. He spent more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional perspective on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a lot of his finest choices in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully predicted a few of the most significant financial occasions of the past twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it best every time, but Jeff Brown's accurate forecasts have actually made him legions of devoted fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular financial research study publisher. Brownstone Research study offers several research services with a large variety of specializations - brownstone research stock.
The company is also associated with Bonner & Partners, another well-respected research publisher - jeff brown prediction. On its website, Brownstone says its objective is to offer retail financiers with professional-grade research study: "For too long, the best financial investment research has not been readily available to private financiers. It has actually been normally scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. what is the legacy report predicting. The mission of Brownstone Research study is to make that sort of proprietary research study available to any investors seeking to acquire an edge in the markets. The objective is easy to provide special and rewarding financial investment research study discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise works as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the market, you know that he has a credibility as a King Midas of sorts. jeff brown prediction for 2021. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. last week. might be "the biggest pattern of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two cutting-edge innovations: artificial intelligence and electric vehicles. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the vehicle market's Holy Grail. As you understand, electrical cars and self-driving vehicle stocks have actually been substantial this year, but the Wall Street machine has actually approved hype without much concrete result. Regardless of a drastic boost in competition over the previous few years, Brown still believes Musk has the finest opportunity of putting everything together.
tech might be the magic string that ties everything together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Generally, this innovation would allow you to rent out your car as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the revenues. It sounds crazy, but it might be closed than you think.